Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
Rank in Stocks
#3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Share Price
$4.87
Market Cap
$4.36B
Change (1 day)
-5.47%
Change (1 year)
-15.62%
Country
CN
Trade Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Category
Healthcare
EPS for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
EPS as of 2026 TTM: 0
According to Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2025 | $0.67 | 330.09% |
| 2024 | $0.16 | 130.38% |
| 2023 | $0.07 | 484.48% |
| 2022 | $0.01 | 146.81% |
| 2021 | 0.00 | -108.30% |
| 2020 | $-0.06 | -191.59% |
| 2019 | $0.06 | -40.97% |
| 2018 | $0.10 | -10.36% |
| 2017 | $0.12 | 53.08% |
| 2016 | $0.08 | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | -100.00% |
| 2012 | $0.08 | 34.33% |
| 2011 | $0.06 | 20.60% |
| 2010 | $0.05 | 0.00% |
| 2009 | 0.00 | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
| 2006 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| $13.70 | - |
BE
|
|
| $27.74 | - |
NL
|
